Opportunity Information: Apply for PA 12 118
Apply for PA 12 118
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Technology Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 23, 2012 and posted on Mar 23, 2012.
- Applicants must submit their applications by Jan 7, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: Independent school districts Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Small businesses Public housing authorities/Indian housing authorities For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), offered this grant opportunity to support early-stage research on technology-based tools that can help people living with HIV who also have substance use problems stay connected to HIV medical care and follow their treatment plans. The announcement is specifically for a Clinical Trial Planning Grant (R34), which is designed to help investigators build and refine an intervention and get the groundwork in place for a future, larger clinical trial. In practical terms, the FOA is about developing, pilot testing, and checking the real-world feasibility of technology tools, including mobile devices, that can improve engagement in HIV care and treatment adherence among substance-abusing populations with HIV.
The program emphasizes technology as a way to address common barriers that interfere with consistent HIV care in the context of substance use, such as missed appointments, unstable routines, transportation issues, stigma, competing priorities, and difficulties staying adherent to antiretroviral therapy. Applications were encouraged to test tools that could function in everyday life and real service settings, not just in ideal conditions. While the FOA highlights mobile devices, the intent is broader: it supports technology-enabled strategies that can improve how patients receive support and how clinics and service organizations deliver HIV care.
Research topics were framed around three main directions. First, projects could focus on patient-level interventions where technology directly supports outcomes like medication adherence, appointment keeping, retention in care, and other behaviors tied to viral suppression and overall health. Examples of the kinds of functions that fit this category include reminders, interactive self-management supports, symptom or side-effect tracking, two-way messaging, motivational or behavioral content, or other mobile or digital features aimed at helping participants stick with treatment and maintain regular care. Second, projects could concentrate on the readiness and capacity of HIV treatment providers or related organizations to adopt and integrate these technologies. That means studying implementation questions like staff workflow, training needs, acceptability, sustainability, privacy and confidentiality considerations, and the practical steps needed to embed a tool into routine care so it actually gets used. Third, projects could target the organization and delivery of HIV treatment and services, using technology to improve coordination, efficiency, and continuity across systems of care, such as strengthening communication between medical providers and support services or improving how care teams track and respond to patients who are falling out of care.
As an R34 planning and pilot mechanism, the grant was not mainly about running a fully powered efficacy trial. Instead, it supported the preparatory and feasibility work that makes a future clinical trial credible and well designed. That typically includes refining the intervention and its technical components, establishing recruitment and retention procedures for a population that can be hard to engage, testing data collection and outcome measures, confirming usability and acceptability, setting up clinical and research workflows, and generating pilot data to justify the next-stage study. The overall goal is to reduce the risk of failure in a later, larger trial by ensuring the intervention and study design are workable, relevant, and ready for more definitive testing.
Funding was offered as a discretionary grant under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The posted date for the opportunity was March 23, 2012, with an original and current closing date listed as January 7, 2015, and an archive date of February 7, 2015. The award ceiling was $225,000, and there was no cost-sharing or matching requirement, which is typical for many NIH research grants.
Eligibility was broad and included many types of organizations capable of conducting health research, intervention development, and clinical trial planning. Eligible applicants included public and private institutions of higher education, nonprofits with or without 501(c)(3) status, small businesses, for-profit organizations (including those other than small businesses), independent school districts, city/county/state and special district governments, public housing authorities/Indian housing authorities, and tribal governments and tribal organizations. The FOA also explicitly included a wide range of additional eligible entities such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. Non-U.S. entities (foreign institutions) were eligible to apply, and foreign components of U.S. organizations were allowed consistent with NIH policy.
The administering agency was NIH (with NIDA as the issuing institute). The full announcement was available through the NIH Grants Guide at the provided link (PA 12-118). For access or technical issues, the listed point of contact was the NIH Office of Extramural Research (OER) webmaster via the provided email addresses.
Frequently Asked Questions (FAQs)
What is the purpose of this grant opportunity?
This funding opportunity from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), supports early-stage research on technology-based tools to help people living with HIV who also have substance use problems stay engaged in HIV medical care and follow their treatment plans (including antiretroviral therapy adherence).
Which NIH institute is offering this opportunity?
The opportunity is offered by NIH, with NIDA identified as the issuing institute.
What type of NIH grant mechanism is this?
This is a Clinical Trial Planning Grant (R34). It is designed to help investigators develop and refine an intervention and complete the preparatory work needed for a future, larger clinical trial.
Is this grant meant to fund a full-scale efficacy clinical trial?
No. The R34 mechanism is primarily for planning, development, pilot testing, and feasibility work rather than running a fully powered efficacy trial.
What kinds of technology-based tools are in scope?
The focus is on technology-enabled strategies, including mobile devices, that can improve engagement in HIV care and treatment adherence among substance-abusing populations with HIV. While mobile devices are highlighted, the intent is broader and includes technology tools that can work in real-world service settings.
Who is the target population for the proposed interventions?
People living with HIV who also have substance use problems, particularly those facing barriers that interfere with consistent HIV care and adherence to treatment plans.
What barriers is the program trying to address?
The program emphasizes technology as a way to address barriers such as missed appointments, unstable routines, transportation challenges, stigma, competing priorities, and difficulties maintaining adherence to antiretroviral therapy.
What kinds of outcomes or behaviors can the technology support at the patient level?
Patient-level interventions may focus on outcomes such as medication adherence, appointment keeping, retention in care, and other behaviors tied to viral suppression and overall health.
What are examples of features or functions that could fit patient-level interventions?
Examples described include reminders, interactive self-management supports, symptom or side-effect tracking, two-way messaging, motivational or behavioral content, and other mobile or digital features aimed at supporting treatment adherence and regular care engagement.
What implementation or provider-organization topics are supported?
Projects may examine readiness and capacity for HIV treatment providers or related organizations to adopt and integrate technology tools. This includes studying workflow, training needs, acceptability, sustainability, privacy and confidentiality considerations, and steps needed to embed a tool into routine care so it is actually used.
Can a project focus on improving how HIV services are organized and delivered across systems?
Yes. A supported direction is improving organization and delivery of HIV treatment and services using technology, including improving coordination, efficiency, and continuity across systems of care (for example, strengthening communication between medical providers and support services or improving how teams track and respond to patients falling out of care).
What kinds of activities does an R34 planning and pilot grant typically support under this announcement?
Typical activities described include refining the intervention and its technical components, establishing recruitment and retention procedures, testing data collection and outcome measures, confirming usability and acceptability, setting up clinical and research workflows, and generating pilot data to justify the next-stage study.
What is the overall goal of doing feasibility and planning work under this FOA?
The goal is to reduce the risk of failure in a later, larger trial by ensuring the intervention and study design are workable, relevant, and ready for more definitive testing.
What is the maximum award amount (award ceiling)?
The award ceiling listed is $225,000.
Is cost-sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
What is the CFDA number associated with this funding?
The funding is identified as a discretionary grant under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
When was this opportunity posted?
The posted date listed is March 23, 2012.
What were the closing date and archive date for this opportunity?
The original and current closing date listed is January 7, 2015, and the archive date is February 7, 2015.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits with or without 501(c)(3) status; small businesses; for-profit organizations (including those other than small businesses); independent school districts; city/county/state and special district governments; public housing authorities/Indian housing authorities; and tribal governments and tribal organizations.
Are minority-serving institutions and community-based organizations eligible?
Yes. The FOA explicitly includes a wide range of eligible entities such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, and regional organizations.
Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are listed among eligible entities.
Are federal agencies eligible applicants?
Yes. The FOA indicates eligible federal agencies are included.
Can non-U.S. (foreign) institutions apply?
Yes. Non-U.S. entities (foreign institutions) were eligible to apply.
Are foreign components of U.S. organizations allowed?
Yes. Foreign components of U.S. organizations were allowed, consistent with NIH policy.
Where was the full announcement made available?
The full announcement was available through the NIH Grants Guide and is identified as PA 12-118.
Who is listed as the contact for access or technical issues with the announcement?
For access or technical issues, the listed point of contact is the NIH Office of Extramural Research (OER) webmaster via the provided email addresses in the announcement.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: OJJDP FY 2012 Childrens Advocacy Centers Membership and Accreditation Program
Previous opportunity: Technology Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 12 118
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 12 118) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 12 145 Funding Number: PAR 12 145 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 12 144 Funding Number: PAR 12 144 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol associated Cancers (R01) Apply for PA 12 146 Funding Number: PA 12 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol associated Cancers (R21) Apply for PA 12 147 Funding Number: PA 12 147 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Senior Scientist Research Award (K05) Apply for PA 12 048 Funding Number: PA 12 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24) Apply for RFA CA 12 503 Funding Number: RFA CA 12 503 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Target Discovery and Development (CTDD) Network (U01) Apply for RFA CA 12 006 Funding Number: RFA CA 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| U.S. China Program for Biomedical Collaborative Research (R01) Apply for RFA AI 12 021 Funding Number: RFA AI 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NLM Administrative Supplements for Informationist Services in NIH funded Research Projects (Admin Supp) Apply for PA 12 158 Funding Number: PA 12 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Senior Scientist Research Award (K05) Apply for PA 12 148 Funding Number: PA 12 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Research on HIV Persistence (R21) Apply for PA 12 162 Funding Number: PA 12 162 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Basic Research on HIV Persistence (R01) Apply for PA 12 161 Funding Number: PA 12 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Sequencing Exploratory Research (U01) Apply for RFA HG 12 009 Funding Number: RFA HG 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,500,000 |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 12 171 Funding Number: PA 12 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Pre Application for the FY13 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 12 164 Funding Number: PAR 12 164 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| FY13 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 13 002 Funding Number: RFA DA 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01) Apply for RFA DA 13 007 Funding Number: RFA DA 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Synthesis and Preclinical Evaluation of Medications to Treat Substance Use Disorders (SUDs) (R01) Apply for RFA DA 13 004 Funding Number: RFA DA 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) Apply for PA 12 196 Funding Number: PA 12 196 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 12 007 Funding Number: RFA CA 12 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 12 118", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
